Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

Authors
Publication date
1 January 2024
Publisher
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Florence Research

      redirect
      oaioai:flore.unifi.it:2158/140475...
      Last time updated on 27/12/2024